1. Home
  2. KODK vs ARDX Comparison

KODK vs ARDX Comparison

Compare KODK & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastman Kodak Company

KODK

Eastman Kodak Company

N/A

Current Price

$9.15

Market Cap

982.9M

ML Signal

N/A

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

N/A

Current Price

$3.71

Market Cap

996.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KODK
ARDX
Founded
1880
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
982.9M
996.8M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
KODK
ARDX
Price
$9.15
$3.71
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$15.14
AVG Volume (30 Days)
899.1K
5.1M
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,114,000,000.00
$2,607,000.00
Revenue This Year
N/A
$37.75
Revenue Next Year
N/A
$34.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.78
$3.68
52 Week High
$14.87
$8.40

Technical Indicators

Market Signals
Indicator
KODK
ARDX
Relative Strength Index (RSI) 46.17 28.49
Support Level $9.13 N/A
Resistance Level $10.20 $6.47
Average True Range (ATR) 0.35 0.13
MACD -0.11 0.03
Stochastic Oscillator 28.86 17.07

Price Performance

Historical Comparison
KODK
ARDX

About KODK Eastman Kodak Company

Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: